Surmodics to receive $27 million milestone payment from Abbott Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the
Thrombolex, Inc. has received 510(k) clearance for use of the BASHIR™ and BASHIR™ S-B Endovascular Catheters for the treatment of acute pulmonary.
Complications Decrease Significantly in Procedure to Open Clogged Pulmonary Arteries miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Complications after a minimally invasive balloon pulmonary angioplasty have decreased substantially over the last decade for patients with high blood pressure in their pulmonary arteries caused by chronic blood clots, known as CTEPH. The procedure, which is offered for patients who are not candidates for surgery, involves inflating a balloon inside of diseased lung arteries to break up clots and restore blood flow to the lungs.